 |
|
|
| |
Associations with weight change and patient reported outcomes after switching from efavirenz/emtricitabine/tenofovir disoproxil fumarate (EFV/FTC/TDF) to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF)
|
| |
| |
Download the PDF here
Glasgow 2020 Oct 5-8 virtual
Reported by Jules Levin
E Lowman1, P Hardigan2, N Unger3and N Lee1
1Midland Research Group, Oakland Park, FL, USA; 2Nova Southeastern University, Fort Lauderdale, FL, USA; 3Gilead Sciences, Inc., Foster City, CA, USA
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0063623
|
| |
|
|
|
|
|
